Article
SOX2 confers tumour permissiveness in a specific skin progenitor population.
Nature communications - 8 Jan 2026
Centeno Patricia P, Chester Christopher, Kanellos Georgios, Ford Catriona A, Cammareri Patrizia, Inman Gareth J, Jamieson Thomas, Ridgway Rachel A, Marais Richard, Campbell Andrew D, Sansom Owen J
Abstract excerpt
The continuous renewal of the skin relies on stem and progenitor cells, yet their differential susceptibility to oncogenic mutations in cutaneous squamous cell carcinoma (cSCC) remains unclear. Rapid cSCC develops in melanoma patients on BRAF inhibitors due to paradoxical MAPK activation. To model this in mice, we use two complementary approaches: HRASG12V with a BRAF inhibitor to mimic paradoxical MAPK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
